Risks of Gastroesophageal Reflux in the Endotracheal Intubation or the I-gel
Primary Purpose
Gastroesophageal Reflux in Laparoscopy
Status
Unknown status
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
i-gel
endotracheal tube
Sponsored by
About this trial
This is an interventional other trial for Gastroesophageal Reflux in Laparoscopy
Eligibility Criteria
Inclusion Criteria:
- Patients who will receive scheduled surgery with laparoscopic pneumoperitoneum and Trendelenburg (LPT) setting under general anesthesia
- Aged from 20-80 years old
Exclusion Criteria:
- Major systemic disease, such as congestive heart failure, liver cirrhosis, end stage renal disease and malignancy.
- Patients who have the risk of difficult ventilation or intubation.
- pregnant women
- coagulopathy
Sites / Locations
- Chih-Jun LaiRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
i-gel
endotracheal tube
Arm Description
After anesthetic durg given, i-gel, a supraglottic airway devices with a gastric suction channel, will be inserted into the patients' airway.
After anesthetic durg given, the endotracheal tube, traditional use for protect airway during the laparoscopic surgery, will be inserted into the patients' airway.
Outcomes
Primary Outcome Measures
gastroesophageal reflux occurence
occurence of the gastroesophageal reflux
Secondary Outcome Measures
lower esophageal sphincter change
lower esophageal sphincter change during the surgery
Full Information
NCT ID
NCT03634449
First Posted
August 9, 2018
Last Updated
January 8, 2019
Sponsor
National Taiwan University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03634449
Brief Title
Risks of Gastroesophageal Reflux in the Endotracheal Intubation or the I-gel
Official Title
Comparing the Gastroesophageal Reflux on Endotracheal Intubation or the I-gel- Second Generation Supraglottic Airway Device in the Pneumoperitoneum and Trendelenburg Surgical Setting
Study Type
Interventional
2. Study Status
Record Verification Date
August 2018
Overall Recruitment Status
Unknown status
Study Start Date
August 13, 2018 (Actual)
Primary Completion Date
October 13, 2019 (Anticipated)
Study Completion Date
September 13, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Taiwan University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
In the use of the second supraglottic airway device- i-gel in the laparoscopic pneumoperitoneum and Trendelenburg (LPT) surgical positioning, our data reported that the leak fraction in the i-gel group was higher than in the endotracheal tube group.1 These air leak may be gone into the GI tract and cause the gastric distension resulting in the increasing risk of aspiration. Few studies investigated whether the risk of occurrence of the gastroesophageal reflux (GER), the changes of the lower esophageal sphincter (LES) while the GER occurred, and the stomach fullness in the i-gel group than in the endotracheal tube group.
We aim to observe the changes of gastroesophageal function parameters by esophageal manometry, pH impedance, and intra-abdominal pressure before and after laparoscopic pneumoperitoneum during anesthesia, all via the second SADs.
Detailed Description
Background: In the use of the second supraglottic airway device- i-gel in the laparoscopic pneumoperitoneum and Trendelenburg (LPT) surgical positioning, our data reported that the leak fraction in the i-gel group was higher than in the endotracheal tube group.1 These air leak may be gone into the GI tract and cause the gastric distension resulting in the increasing risk of aspiration. Few studies investigated whether the risk of occurrence of the gastroesophageal reflux (GER), the changes of the lower esophageal sphincter (LES) while the GER occurred, and the stomach fullness in the i-gel group than in the endotracheal tube group. The LES is the important physiological mechanisms that prevent regurgitation and aspiration. The previous study has been investigated that LES would have adaptive response in using the endotracheal tube in the LPT setting. However, the change of LES pressure and gastroesophageal reflux during the LPT surgical settings using the i-gel is still unknown.
The esophageal manometry has pressure sensor to measure the LES pressure. The combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) could not only detect the acidic reflux or weakly acidic reflux, but also the height of the regurgitant. We also used the abdominal echo in check the gastric volume before and after the surgery.
Objectives: we aimed to compare the changes of lower esophageal sphincter pressure (LESP) and the occurrence of the GER during the LPT setting by esophageal manometry and MII-pH monitor between the endotracheal tube (ETT) and the i-gel group. The gastric volume before and after surgery has been checked by abdominal echo. We also observed the respiratory parameters changes while the GER occurred.
Patients and methods: Consecutive patients who will receive scheduled laparoscopic surgery under general anesthesia and aged from 20 to 80 years old will be enrolled. All subjects provide basic demographic data. The patients have been randomized into the i-gel or ETT group by sealing envelope. After induction, the MII-pH monitor has been pre-attached to the esophageal manometry. Then they will be inserted into the esophagus. The patients have received the ETT or i-gel. Then the respiratory parameters were collected by the GE S/5 Compact Anesthesia Monitor (GE Healthcare, Helsinki, Finland) with a spirometry tube (GE Healthcare, Helsinki, Finland) and D-lite sensor (GE Healthcare, Helsinki, Finland). The data have been continuous recorded. There were four time point of the LESP measured: (1)T1, after induction (without muscle relaxant) (2)T2, ETT or i-gel intubation (3)T3, after LPT setting (4) T4, off LPT setting.
Expected result: We will compared the difference between the patients receiving the i-gel or ETT group about the (1) the changes of LESP in the above four time point (2) the occurrence of the GER and the relationship between the LES and GER (3) gastric volume before and after surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastroesophageal Reflux in Laparoscopy
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
one group using the endotracheal tube one group using the i-gel
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
i-gel
Arm Type
Experimental
Arm Description
After anesthetic durg given, i-gel, a supraglottic airway devices with a gastric suction channel, will be inserted into the patients' airway.
Arm Title
endotracheal tube
Arm Type
Active Comparator
Arm Description
After anesthetic durg given, the endotracheal tube, traditional use for protect airway during the laparoscopic surgery, will be inserted into the patients' airway.
Intervention Type
Device
Intervention Name(s)
i-gel
Intervention Description
i-gel is a supraglottic airway devices with a gastric suction channel.
Intervention Type
Device
Intervention Name(s)
endotracheal tube
Intervention Description
Endotracheal intubation is a traditional use for protect airway during the laparoscopic surgery.
Primary Outcome Measure Information:
Title
gastroesophageal reflux occurence
Description
occurence of the gastroesophageal reflux
Time Frame
during the surgery
Secondary Outcome Measure Information:
Title
lower esophageal sphincter change
Description
lower esophageal sphincter change during the surgery
Time Frame
during the surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who will receive scheduled surgery with laparoscopic pneumoperitoneum and Trendelenburg (LPT) setting under general anesthesia
Aged from 20-80 years old
Exclusion Criteria:
Major systemic disease, such as congestive heart failure, liver cirrhosis, end stage renal disease and malignancy.
Patients who have the risk of difficult ventilation or intubation.
pregnant women
coagulopathy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chih-Jun Lai, MD
Phone
0965327939
Email
littlecherrytw@gmail.com
Facility Information:
Facility Name
Chih-Jun Lai
City
Taipei
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chih-Jun Lai
Phone
+886965327939
Ext
+886965327939
Email
littlecherrytw@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
due to the privacy of the individual participant data of our patients, we cannot share their data to other researchers.
The raw data will be kept very carefully in our research team.
Learn more about this trial
Risks of Gastroesophageal Reflux in the Endotracheal Intubation or the I-gel
We'll reach out to this number within 24 hrs